Description
MK-2461 is an inhibitor of MET that also shows inhibition of FGFR and PDGFR. In animal models of glioblastoma and gastric cancer, MK-2461 exhibits anticancer chemotherapeutic activity, decreasing tumor growth and size.
Product Unit Size | Cost | Quantity | Stock |
---|
MK-2461 is an inhibitor of MET that also shows inhibition of FGFR and PDGFR. In animal models of glioblastoma and gastric cancer, MK-2461 exhibits anticancer chemotherapeutic activity, decreasing tumor growth and size.
Cas No. | 917879-39-1 |
---|---|
Purity | ≥99% |
Formula | C24H25N5N5S |
Formula Wt. | 495.55 |
Chemical Name | 9-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridine |
IUPAC Name | 9-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridine |
Synonym | MK2461 |
Solubility | DMSO 99 mg/mL (199.77 mM) Water Insoluble Ethanol Insoluble |
Appearance | Yellow Solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Katz JD, Jewell JP, Guerin DJ, et al. Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer. J Med Chem. 2011 Jun 23;54(12):4092-108. PMID: 21608528.
Pan BS, Chan GK, Chenard M, et al. MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor. Cancer Res. 2010 Feb 15;70(4):1524-33. PMID: 20145145.
Akt inhibitor.
Polyether Ca2+ ionophore.
Peptide, used as control to measure RGDS peptid...
Potential AhR binding agent.
Synthetic ITC.
Valosin-containing protein inhibitor.
Triterpene saponin found in species of Panax.
Lignin found in Sesamin indicum;
Phenol found in Zingiber; 5-HT3 antagonist.
2-methyl-1,4-naphthoquinone derivative
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Organosulfur found in garlic.
ACE inhibitor.
Cyclosporin metabolite; formyl peptide inhibito...
Antiviral againt SARS-CoV-2
α2-adrenergic and imidazoline-1 antagonist, AT...
Endogenous peptide hormone; guanyl cyclase C ag...
Aspartyl protease inhibitor.
Synthetic steroid hormone; ER antagonist.
Dual inhibitor of p70S6K and Akt.